Glycemic improvements as a result of EMPA treatment have been demonstrated to ameliorate cognitive impairment, attenuate oxidative stress and inflammation, and significantly increase brain-derived neurotrophic factor (BDNF) in cerebral tissues of T2DM db/db mice [8]. Here, BDNF is linked to Cognitive impairment.